Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 3
391
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Indole-3-propionic acid attenuates high glucose induced ER stress response and augments mitochondrial function by modulating PERK-IRE1-ATF4-CHOP signalling in experimental diabetic neuropathy

, , , &
Pages 243-256 | Received 17 Sep 2021, Accepted 27 Dec 2021, Published online: 11 Jan 2022
 

Abstract

Objectives

We aimed to evaluate the neuroprotective effect of Indole-3-propionic acid (IPA) against streptozotocin (STZ) induced diabetic peripheral neuropathy (DPN) in rats and in high glucose (HG) induced neurotoxicity in neuro2a (N2A) cells.

Methods

Diabetes was induced in male SD rats STZ (55 mg/kg, i.p.) and IPA (10 and 20 mg/kg, p.o.) was administered for two weeks, starting from sixth week after diabetes induction. Neurobehavioral, functional assessments were made, and various molecular studies were performed to evaluate the effect of IPA on HG induced ER stress and mitochondrial dysfunction in sciatic nerves, DRGs and in N2A cells.

Results

Diabetic rats and high glucose exposed N2A cells showed marked increase in oxidative damage accompanied by ER stress and mitochondrial dysfunction along with increased apoptotic markers. IPA treatment for two weeks markedly alleviated these changes and attenuated pain behaviour.

Conclusion

IPA exhibited neuroprotective activity against hyperglycaemic insults.

Disclosure statement

The authors have no conflicts of interest to declare.

Data availability statement

The data that support the findings of this study are available on request from the corresponding author upon reasonable request.

Additional information

Funding

The authors are grateful for the financial support of Department of Science and Technology (DST), Women Scientist Scheme-A (WOS-A) [grant number: SR/WOS-A/LS-485/2017] to carry out this study and NIPER-Hyderabad, India, in the preparation of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.